CFDE Data Portal | Search STARD4

	Label	Description
	STARD4-AS1 Gene (Entity type)	ENSG00000246859 - STARD4 antisense RNA 1
	STARD4 associations Collection (Entity type)	Associations for STARD4_associations
	STARD4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	STARD4-AS1 associations Collection (Entity type)	Associations for STARD4-AS1_associations
	STARD4-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	STARD4 Gene (Entity type)	ENSG00000164211 - StAR related lipid transfer domain containing 4
	GSE168473 0 V 1 ISONIAZID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE147662 3 V 1 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

STARD4-AS1

ENSG00000246859 - STARD4 antisense RNA 1

STARD4 associations

Associations for STARD4_associations

STARD4 associations.tsv

A file from IDG as part of the Harmonizome project

STARD4-AS1 associations

Associations for STARD4-AS1_associations

STARD4-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

STARD4

ENSG00000164211 - StAR related lipid transfer domain containing 4

GSE168473 0 V 1 ISONIAZID HUMAN UP

A Gene Set from LINCS

GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN

A Gene Set from LINCS

GSE147662 3 V 1 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

GSE226249 pirfenidone HL 0 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.